Sensus Healthcare Partners with ROS to Expand U.S. Distribution of Superficial Radiotherapy Systems

Reuters

06-26

Sensus Healthcare Partners with ROS to Expand U.S. Distribution of Superficial Radiotherapy Systems

Sensus Healthcare Inc. has announced a strategic partnership with Radiology Oncology Systems (ROS) to expand the distribution of its superficial radiotherapy $(SRT)$ systems in the U.S. oncology market. This agreement designates ROS as the primary distribution partner for Sensus's SRT systems, including the SRT-100™ and SRT-100 Vision™, targeting hospital-based and freestanding oncology centers nationwide. The collaboration aims to increase the adoption of Sensus's non-invasive radiotherapy technologies, recognized for their effective aesthetic outcomes and minimal disruption to clinical workflows. Initial product orders are anticipated by the fourth quarter of 2025, with prospects for international market expansion in the future.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sensus Healthcare Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250626809602) on June 26, 2025, and is solely responsible for the information contained therein.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2546780593"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2546780593\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2546780593?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-06-26 20:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2546780593","market":"us","top_or_hot":-1,"title":"Sensus Healthcare Partners with ROS to Expand U.S. Distribution of Superficial Radiotherapy Systems","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Sensus Healthcare Partners with ROS to Expand U.S. Distribution of Superficial Radiotherapy Systems\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Sensus Healthcare Inc. has announced a strategic partnership with Radiology Oncology Systems (ROS) to expand the distribution of its superficial radiotherapy <a href=\"https://laohu8.com/S/SRT\">$(SRT)$</a> systems in the U.S. oncology market. This agreement designates ROS as the primary distribution partner for Sensus's SRT systems, including the SRT-100™ and SRT-100 Vision™, targeting hospital-based and freestanding oncology centers nationwide. The collaboration aims to increase the adoption of Sensus's non-invasive radiotherapy technologies, recognized for their effective aesthetic outcomes and minimal disruption to clinical workflows. Initial product orders are anticipated by the fourth quarter of 2025, with prospects for international market expansion in the future.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sensus Healthcare Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250626809602) on June 26, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sensus Healthcare Partners with ROS to Expand U.S. Distribution of Superficial Radiotherapy Systems</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSensus Healthcare Partners with ROS to Expand U.S. Distribution of Superficial Radiotherapy Systems\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-06-26 20:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Sensus Healthcare Partners with ROS to Expand U.S. Distribution of Superficial Radiotherapy Systems\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Sensus Healthcare Inc. has announced a strategic partnership with Radiology Oncology Systems (ROS) to expand the distribution of its superficial radiotherapy <a href=\"https://laohu8.com/S/SRT\">$(SRT)$</a> systems in the U.S. oncology market. This agreement designates ROS as the primary distribution partner for Sensus's SRT systems, including the SRT-100™ and SRT-100 Vision™, targeting hospital-based and freestanding oncology centers nationwide. The collaboration aims to increase the adoption of Sensus's non-invasive radiotherapy technologies, recognized for their effective aesthetic outcomes and minimal disruption to clinical workflows. Initial product orders are anticipated by the fourth quarter of 2025, with prospects for international market expansion in the future.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sensus Healthcare Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250626809602) on June 26, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"医疗保健设备","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250626:nNDL6Lg875:1","article_id":"2546780593","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2546780593","pubTimestamp":1750939287,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Sensus Healthcare Inc. has announced a strategic partnership with Radiology Oncology Systems  to expand the distribution of its superficial radiotherapy  systems in the U.S. oncology market. This agreement designates ROS as the primary distribution partner for Sensus's SRT systems, including the SRT-100 and SRT-100 Vision, targeting hospital-based and freestanding oncology centers nationwide. The collaboration aims to increase the adoption of Sensus's non-invasive radiotherapy technologies, recognized for their effective aesthetic outcomes and minimal disruption to clinical workflows. Initial product orders are anticipated by the fourth quarter of 2025, with prospects for international market expansion in the future.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","SRTS":"Sensus Healthcare, Inc."},"translate_title":"Sensus Healthcare与ROS合作扩大浅表放射治疗系统在美国的分销","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SRTS":0.9},"content_text":"Sensus Healthcare Partners with ROS to Expand U.S. Distribution of Superficial Radiotherapy Systems\n    \n\n        Sensus Healthcare Inc. has announced a strategic partnership with Radiology Oncology Systems (ROS) to expand the distribution of its superficial radiotherapy $(SRT)$ systems in the U.S. oncology market. This agreement designates ROS as the primary distribution partner for Sensus's SRT systems, including the SRT-100™ and SRT-100 Vision™, targeting hospital-based and freestanding oncology centers nationwide. The collaboration aims to increase the adoption of Sensus's non-invasive radiotherapy technologies, recognized for their effective aesthetic outcomes and minimal disruption to clinical workflows. Initial product orders are anticipated by the fourth quarter of 2025, with prospects for international market expansion in the future.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sensus Healthcare Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250626809602) on June 26, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}